Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative?
dc.contributor.author | Hindilerden, Fehmi | |
dc.contributor.author | Yonal-Hindilerden, Ipek | |
dc.contributor.author | Diz-Kucukkaya, Reyhan | |
dc.date.accessioned | 2019-08-13T12:10:23Z | |
dc.date.accessioned | 2019-08-13T15:56:17Z | |
dc.date.available | 2019-08-13T12:10:23Z | |
dc.date.available | 2019-08-13T15:56:17Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 1076-1608 | |
dc.identifier.issn | 1536-7355 | |
dc.identifier.uri | http://hdl.handle.net/11446/2268 | |
dc.description | WOS: 000408513200012 | en_US |
dc.description | PubMed ID: 28832383 | en_US |
dc.description.abstract | … | en_US |
dc.language.iso | eng | en_US |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative? | en_US |
dc.type | letter | en_US |
dc.relation.journal | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.volume | 23 | en_US |
dc.identifier.startpage | 350 | en_US |
dc.identifier.endpage | 353 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.department-temp | [Hindilerden, Fehmi] Istanbul Univ, Istanbul Bakirkoy Sadi Konuk Training & Res Hosp, Istanbul Fac Med, Dept Internal Med,Div Hematol,Hematol Clin, Istanbul, Turkey -- Istanbul Bilim Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey | en_US |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
PubMed İndeksli Yayınlar Koleksiyonu [1488]
PubMed Indexed Publications Collection -
WoS İndeksli Yayınlar Koleksiyonu [2110]
WoS Indexed Publications Collection